Remove Drugs Remove Generic Drugs Remove Pharma Companies Remove Pharmacy
article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. Then there is the cost of generic drugs. bilĀ­lion in 2020 if it had purĀ­chased 77 of 89 drugs from Cuban’s firm. Not if it affects their bottom line.

Pharmacy 227
article thumbnail

PBMs and insurers want your prescription money

World of DTC Marketing

The drug industry deserves its share of the blame for the high prices of medications, but the truth is that prescription medications are so profitable that many others want their share of the money. Pharma companies have very little control over patients’ prices for their Rxs. Let’s take a step back for a minute.

Pharmacy 226
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cybersecurity in pharma: Securing the future

Pharmaceutical Technology

Earlier this year, Sun Pharmaceutical Industries , one of Indiaā€™s largest generic drug producers, reported a major cybersecurity breach , impacting its business operations. Pharma companies around the world have also faced similar threats , some of which have impacted national security and public health.

article thumbnail

Californiaā€™s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

CivicaRx is a non-profit generic drug company producing affordable insulin biosimilars in collaboration with the Juvenile Diabetes Research Foundation (JDRF). Most of the US insulin market is controlled by three pharma companies: Sanofi, Eli Lilly, and Novo Nordisk. In-house manufacturing the norm.

Insulin 328
article thumbnail

Pharmaā€™s climate change vulnerability and opportunity

pharmaphorum

Pharma companies are ā€œhighly vulnerableā€ to the effects of climate change, due to their reliance on global networks. In 2017, the global medicines supply was interrupted when Hurricane Maria hit Puerto Rico, home to more than 500 medical product facilities and producer of 10% of all drugs consumed in America. Vulnerability .

article thumbnail

European Commission vs Big Pharma, or profit vs access? Ā 

Drug Discovery World

Politico published a summary of the key propositions outlined in the draft 2 , and DDWā€™s Multimedia Editor Megan Thomas investigates their intention, and observes how the industry has responded. Key proposals Approved drugs must launch in all EU countries within two years Politico described this as a measure to ensure a level playing field.

article thumbnail

India: Why is the country ramping up drug discovery research?

Drug Discovery World

DDWā€™s Megan Thomas takes a deeper look into why India is ramping up drug discovery research, and explores the countryā€™s innovation hubs of interest. According to a report by Deloitte, globally India is the third largest in the world by volume and 11th by value, comprising over 3,000 pharma companies and 10,500 manufacturing facilities 2.